Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Green, Ben
1999.
Focus on Olanzapine.
Current Medical Research and Opinion,
Vol. 15,
Issue. 2,
p.
79.
Fleischhacker, W. Wolfgang
1999.
The psychopharmacology of schizophrenia.
Current Opinion in Psychiatry,
Vol. 12,
Issue. 1,
p.
53.
Tran, Pierre V.
Tollefson, Gary D.
Sanger, Todd M.
Lu, Yili
Berg, Paul H.
and
Beasley, Charles M.
1999.
Olanzapine versus haloperidol in the treatment of schizoaffective disorder.
British Journal of Psychiatry,
Vol. 174,
Issue. 1,
p.
15.
Fleischhacker, W. Wolfgang
1999.
Invited comment.
Acta Psychiatrica Scandinavica,
Vol. 100,
Issue. 4,
p.
314.
Stephenson, C. M. E.
and
Pilowsky, L. S.
1999.
Psychopharmacology of olanzapine.
British Journal of Psychiatry,
Vol. 174,
Issue. S38,
p.
52.
Kane, John
1999.
Olanzapine in the long-term treatment of schizophrenia.
British Journal of Psychiatry,
Vol. 174,
Issue. S37,
p.
26.
Massie, Jennifer
and
Lewis, Shôn
1999.
Duration of treatment in schizophrenia.
The Journal of Forensic Psychiatry,
Vol. 10,
Issue. 3,
p.
491.
Tollefson, Gary D.
and
Taylor, Cindy C.
2000.
Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent.
CNS Drug Reviews,
Vol. 6,
Issue. 4,
p.
303.
Dose, M.
2000.
Langzeittherapie der Schizophrenie.
p.
37.
Duggan, L
Fenton, M
Dardennes, RM
El-Dosoky, A
and
Indran, S
2000.
Cochrane Database of Systematic Reviews.
Meltzer, Herbert Y.
2000.
Atypical Antipsychotics.
p.
191.
Sacristán, José A.
Gómez, Juan-Carlos
Montejo, Angel-Luis
Vieta, Eduardo
and
Gregor, Karl J.
2000.
Doses of olanzapine, risperidone, and haloperidol used in clinical practice: Results of a prospective pharmacoepidemiologic study.
Clinical Therapeutics,
Vol. 22,
Issue. 5,
p.
583.
Möller, Hans-Jürgen
2000.
Definition, Psychopharmacological Basis and Clinical Evaluation of Novel/Atypical Neuroleptics: Methodological Issues and Clinical Consequences.
The World Journal of Biological Psychiatry,
Vol. 1,
Issue. 2,
p.
75.
Lund, Brian C
and
Perry, Paul J
2000.
Olanzapine: an atypical antipsychotic for schizophrenia.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 2,
p.
305.
Marder, Stephen R.
2000.
Newer antipsychotics.
Current Opinion in Psychiatry,
Vol. 13,
Issue. 1,
p.
11.
Fleischhacker, W. W.
2000.
Psychiatrie der Gegenwart 5.
p.
209.
Revicki, Dennis A
2000.
The new atypical antipsychotics: a review of pharmacoeconomic studies.
Expert Opinion on Pharmacotherapy,
Vol. 1,
Issue. 2,
p.
249.
LAURIELLO, JOHN
and
BUSTILLO, JUAN
2001.
Medication Treatments for Schizophrenia: Translating Research Findings into Better Outcomes.
Journal of Psychiatric Practice,
Vol. 7,
Issue. 4,
p.
260.
Ishigooka, Jun
Inada, Toshiya
and
Miura, Sadanori
2001.
Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double‐blind olanzapine trial.
Psychiatry and Clinical Neurosciences,
Vol. 55,
Issue. 4,
p.
403.
Kane, John
2001.
Progress defined-short-term efficacy, long-term effectiveness.
International Clinical Psychopharmacology,
Vol. 16,
Issue. Supplement 1,
p.
S1.
eLetters
No eLetters have been published for this article.